MAPT and Alzheimer disease: The pathological hallmarks of AD (Aβ and tau neurofibrillary tangles [NFTs]) can be diagnosed in cerebrospinal fluid (CSF) and tau positron emission tomography (PET) with additional neuroimaging tools like single‐photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) for neurodegeneration.